群馬大学 未来先端研究機構 > 遺伝子治療学研究部門 > 横堀研究室 > 横堀 武彦

Members

略歴

2019年 4月~現在 群馬大学 未来先端研究機構 統合腫瘍学研究部門 准教授
2018年 8月 群馬大学先端腫瘍免疫治療学講座 特任准教授
2018年 5月 群馬大学がん治療臨床開発学講座 特任准教授
2016年10月 群馬大学未来先端研究機構 講師
2015年 4月 群馬大学病態腫瘍薬理学 講師
2013年 4月 群馬大学病態総合外科学 助教
2010年 7月 群馬大学医学部附属病院外科 医員
2007年 4月 九州大学別府生体防御医学研究所
2006年 4月 群馬県済生会前橋病院外科 医員
2005年 4月 群馬大学医学部附属病院外科
2004年 4月 群馬県藤岡総合病院外科
2003年 6月 大分県中津市民病院外科
2002年 5月 群馬大学病態総合外科学
2002年 3月 聖マリアンナ医科大学医学部医学科 卒業

主要業績

2021

  • Yoshida, T; Yokobori, T; Saito, H; Kuriyama, K; Kumakura, Y; Honjo, H; Hara, K; Sakai, M; Miyazaki, T; Obinata, H; Erkhem-Ochir, B; Gombodorj, N; Sohda, M; Saeki, H; Kuwano, H; Shirabe, K CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma. ANNALS OF SURGICAL ONCOLOGY. 2021 Feb; 28(2): 1217-1227.
  • Bilguun Erkhem-Ochir MD, Wataru Tatsuishi MD,PhD, Takehiko Yokobori MD, PhD,Tsukasa Ohno MD, PhD, KyoheiHatori MD, PhD, Tadashi Handa PhD,Tetsunari Oyama MD, PhD, Ken Shirabe, MD, PhD, Hiroshi Saeki MD,PhD, Tomonobu Abe MD, PhD Inflammatory and immune checkpoint markers are associated with the severity of aortic stenosis. JTCVS. 2021 Jan.
  • Chiavarina, B; Costanza, B; Ronca, R; Blomme, A; Rezzola, S; Chiodelli, P; Giguelay, A; Belthier, G; Doumont, G; Van Simaeys, G; Lacroix, S; Yokobori, T; Erkhem-Ochir, B; Balaguer, P; Cavailles, V; Fabbrizio, E; Di Valentin, E; Gofflot, S; Detry, O; Jerusalem, G; Goldman, S; Delvenne, P; Bellahcene, A; Pannequin, J; Castronovo, V; Turtoi, A Metastatic colorectal cancer cells maintain the TGF beta program and use TGFBI to fuel angiogenesis. THERANOSTICS. 2021 Jan; 11(4): 1626-1640.

2020

  • Kuwano, H; Yokobori, T; Kumakura, Y; Ogata, K; Yoshida, T; Kuriyama, K; Sakai, M; Sohda, M; Miyazaki, T; Saeki, H; Shirabe, K Pathophysiology of Vomiting and Esophageal Perforation in Boerhaave’s Syndrome. DIGESTIVE DISEASES AND SCIENCES. 2020. Nov; 65(11): 3253-3259.
  • Dolgormaa, G; Harimoto, N; Ishii, N; Yamanaka, T; Hagiwara, K; Tsukagoshi, M; Igarashi, T; Watanabe, A; Kubo, N; Araki, K; Handa, T; Yokobori, T; Oyama, T; Kuwano, H; Shirabe, K Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling. BRITISH JOURNAL OF CANCER. 2020 Sep 29; 123(7): 1145-1153.
  • Kubo, N; Yokobori, T; Takahashi, R; Ogawa, H; Gombodorj, N; Ohta, N; Ohno, T; Saeki, H; Shirabe, K; Asao, T An abdominal spacer that does not require surgical removal and allows drainage of abdominal fluids in patients undergoing carbon ion radiotherapy. PLOS ONE. 2020 Jun 10; 15(6): e0234471.
  • Kuriyama, K; Higuchi, T; Yokobori, T; Saito, H; Yoshida, T; Hara, K; Suzuki, S; Sakai, M; Sohda, M; Higuchi, T; Tsushima, Y; Asao, T; Kaira, K; Kuwano, H; Shirabe, K; Saeki, H Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma. CANCER SCIENCE. 2020 Jun; 111(6): 1969-1978.
  • Baatar, S; Bai, T; Yokobori, T; Gombodorj, N; Nakazawa, N; Ubukata, Y; Kimura, A; Kogure, N; Sano, A; Sohda, M; Sakai, M; Tumenjargal, A; Ogata, K; Kuwano, H; Shirabe, K; Saeki, H High RAD18 Expression is Associated with Disease Progression and Poor Prognosis in Patients with Gastric Cancer. ANNALS OF SURGICAL ONCOLOGY. 2020 Oct; 27(11): 4360-4368.
  • Togo, M; Yokobori, T; Shimizu, K; Handa, T; Kaira, K; Sano, T; Tsukagoshi, M; Higuchi, T; Yokoo, S; Shirabe, K; Oyama, T Diagnostic value of F-18-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8(+)tumour-infiltrating lymphocytes in oral squamous cell carcinoma. BRITISH JOURNAL OF CANCER. 2020 May 26; 122(11): 1686-1694.
  • Hagiwara, K; Harimoto, N; Yokobori, T; Muranushi, R; Hoshino, K; Gantumur, D; Yamanaka, T; Ishii, N; Tsukagoshi, M; Igarashi, T; Tanaka, H; Watanabe, A; Kubo, N; Araki, K; Hosouchi, Y; Shirabe, K High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer. ANNALS OF SURGICAL ONCOLOGY. 2020 Mar; 27(3): 924-930.
  • Yamanaka, T; Harimoto, N; Yokobori, T; Muranushi, R; Hoshino, K; Hagiwara, K; Gantumur, D; Handa, T; Ishii, N; Tsukagoshi, M; Igarashi, T; Tanaka, H; Watanabe, A; Kubo, N; Araki, K; Shirabe, K Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts. BRITISH JOURNAL OF CANCER. 2020 Mar; 122(7): 986-994.

2019

  • Shimizu K, Goto Y, Kawabata-Iwakawa R, Ohtaki Y, Nakazawa S, Yokobori T, Obayashi K, Kawatani N, Yajima T, Kaira K, Mogi A, Hirato J, Nishiyama M, Shirabe K. Stathmin-1 is a useful diagnostic marker for high-grade lung neuroendocrine tumors. Ann Thorac Surg. 2019 Mar 22. pii: S0003-4975(19)30392-3.

2018

  • Suzuki K, Watanabe A, Araki K, Yokobori T, Harimoto N, Gantumur D, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Kubo N, Gombodorj N, Nishiyama M, Hosouchi Y, Kuwano H, Shirabe K. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer. Anticancer Res. 2018 Feb;38(2):939-944.

2017

  • Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Bai T, Kawabata-Iwakawa R, Asao T, Kaira K, Nishiyama M, Kuwano H. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma. Ann Surg Oncol. 2017 Dec;24(13):4017-4024.
  • Obayashi S, Horiguchi J, Higuchi T, Katayama A, Handa T, Altan B, Bai T, Bao P, Bao H, Yokobori T, Nishiyama M, Oyama T, Kuwano H. Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients. Int J Oncol. 2017 Sep;51(3):781-790.
  • Shimizu K, Ohtaki Y, Altan B, Yokobori T, Nagashima T, Arai M, Mogi A, Kuwano H. Prognostic impact of stathmin 1 expression in patients with lung adenocarcinoma. J Thorac Cardiovasc Surg. 2017 Oct;154(4):1406-1417.e3.
  • Watanabe A, Araki K, Yokobori T, Altan B, Ishii N, Tsukagoshi M, Kubo N, Saito F, Suzuki H, Kuwano H. Stathmin 1 promotes the proliferation and malignant transformation of pancreatic intraductal papillary mucinous neoplasms. Oncol Lett. 2017 Mar;13(3):1783-1788.
  • Suzuki S, Yokobori T, Altan B, Hara K, Ozawa D, Tanaka N, Sakai M, Sano A, Sohda M, Bao H, Fukuchi M, Miyazaki T, Kaira K, Asao T, Kuwano H. High stathmin 1 expression is associated with poor prognosis and chemoradiation resistance in esophageal squamous cell carcinoma. Int J Oncol. 2017 Mar 7.
  • Bai T, Yokobori T, Altan B, Ide M, Mochiki E, Yanai M, Kimura A, Kogure N, Yanoma T, Suzuki M, Bao P, Kaira K, Asao T, Katayama A, Handa T, Gombodorj N, Nishiyama M, Oyama T, Ogata K, Kuwano H. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients. Br J Cancer. 2017 Apr 25;116(9):1177-1185.

2016

  • Saito F, Araki K, Yokobori T, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Altan B, Shirabe K, Kuwano H. High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction. J Surg Oncol. 2016 Sep;114(4):462-8.

2014

  • Watanabe A, Suzuki H, Yokobori T, Tsukagoshi M, Altan B, Kubo N, Suzuki S, Araki K, Wada S, Kashiwabara K, Hosouchi Y, Kuwano H. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma. Cancer Sci. 2014 Jun;105(6):690-6.

受賞

2018年 膵臓病研究奨励賞 日本膵臓病研究財団
2018年 公益財団法人鈴木謙三記念医科学応用研究財団 平成30年度助成金
2018年 第7回 日本消化器癌発生学会 田原榮一賞
2018年 2018 Annual Meeting of Chinese Society of Clinical Oncology, Travel grant.
2017年 第26回日本癌病態治療研究会 奨励賞
2015年 日本医師会 医学研究奨励賞
2014年 上原記念生命科学財団 研究奨励金
2014年 日本外科学会臨床研究助成
2010年 The 7th International Symposium on Cancer Research and Therapy, Subsidy Award

トップへ戻る